These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 1324639

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents.
    Jacobs MR, Spangler SK, Appelbaum PC.
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1081-93. PubMed ID: 1295763
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity of clinical isolates from German hospitals to amoxicillin/clavulanic acid (Augmentin) compared with other antibiotics.
    Focht J, Klietmann W, Nösner K, Rolinson GN, Johnsen J.
    Chemotherapy; 1988 Nov; 34(4):332-40. PubMed ID: 3264780
    [Abstract] [Full Text] [Related]

  • 8. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nishimura T, Tabuki K, Takashima T, Takagi M.
    Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Susceptibilities of anaerobic gram-negative bacilli to thirteen antimicrobials and beta-lactamase inhibitor combinations.
    Hill GB, Ayers OM, Everett BQ.
    J Antimicrob Chemother; 1991 Dec; 28(6):855-67. PubMed ID: 1816182
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor.
    Coleman K, Griffin DR, Page JW, Upshon PA.
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1580-7. PubMed ID: 2817854
    [Abstract] [Full Text] [Related]

  • 16. [The antimicrobial activity of Augmentin (amoxicillin/clavulanic acid) compared to other antibacterial agents].
    Zubkov MN, Nonikov VE, Gugutsidze EN, Sutormina TM, Makarova OV.
    Antibiot Khimioter; 1992 Sep; 37(9):34-6. PubMed ID: 1444669
    [Abstract] [Full Text] [Related]

  • 17. [Experimental and clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics].
    Motohiro T, Tanaka K, Koga T, Shimada Y, Tomita N, Nishiyama T, Ishimoto K, Tominaga K, Iriki T, Harada M.
    Jpn J Antibiot; 1985 Feb; 38(2):481-506. PubMed ID: 3892076
    [Abstract] [Full Text] [Related]

  • 18. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
    Livermore DM, Seetulsingh P.
    J Antimicrob Chemother; 1991 Jun; 27(6):761-7. PubMed ID: 1669013
    [Abstract] [Full Text] [Related]

  • 19. The effect of anaerobiosis on antistaphylococcal antibiotics.
    Tsukayama DT, Guay DR, Gustilo RB, Wicklund B, Gruninger R, Peterson PK.
    Orthopedics; 1988 Sep; 11(9):1285-9. PubMed ID: 2971930
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.